OBJECTIVE: To develop and test a new instrument for patient self-reported quality of osteoarthritis (OA) care, and to provide quality indicator (QI) pass rates in a Norwegian OA cohort. METHODS: The OsteoArthritis Quality Indicator (OA-QI) questionnaire was developed using published QIs, expert panels, and patient interviews. Self-reported data were collected from 359 persons in a Norwegian OA cohort, and test-retest reliability and validity were assessed. Separate QI pass rates and summary QI pass rates were calculated. RESULTS: The 17-item questionnaire includes QIs related to patient education and information, regular provider assessments, referrals, and pharmacologic treatment. The patient self-reported questionnaire was completed with minimal respondent burden. Support for content validity was confirmed by 2 patient research partners and 2 expert panels. All 10 predefined hypotheses relating to construct validity were confirmed. Test-retest kappa coefficients ranged from 0.20-0.80 and the percentage of exact agreement ranged from 62-90%. The mean pass rate for individual QIs was 31% (range 5-49%). The median summary QI pass rate was 27% (interquartile range 12-50%), with lower summary pass rates for nonpharmacologic compared to pharmacologic treatments. CONCLUSION: To our knowledge, this is the first instrument developed to measure patient-reported QI pass rates for OA care. This study indicates that the OA-QI questionnaire is acceptable to persons with OA, and its short format makes it suitable for population surveys. The low patient self-reported QI pass rates in this study suggest a potential for quality improvement in OA care.
OBJECTIVE: To develop and test a new instrument for patient self-reported quality of osteoarthritis (OA) care, and to provide quality indicator (QI) pass rates in a Norwegian OA cohort. METHODS: The OsteoArthritis Quality Indicator (OA-QI) questionnaire was developed using published QIs, expert panels, and patient interviews. Self-reported data were collected from 359 persons in a Norwegian OA cohort, and test-retest reliability and validity were assessed. Separate QI pass rates and summary QI pass rates were calculated. RESULTS: The 17-item questionnaire includes QIs related to patient education and information, regular provider assessments, referrals, and pharmacologic treatment. The patient self-reported questionnaire was completed with minimal respondent burden. Support for content validity was confirmed by 2 patient research partners and 2 expert panels. All 10 predefined hypotheses relating to construct validity were confirmed. Test-retest kappa coefficients ranged from 0.20-0.80 and the percentage of exact agreement ranged from 62-90%. The mean pass rate for individual QIs was 31% (range 5-49%). The median summary QI pass rate was 27% (interquartile range 12-50%), with lower summary pass rates for nonpharmacologic compared to pharmacologic treatments. CONCLUSION: To our knowledge, this is the first instrument developed to measure patient-reported QI pass rates for OA care. This study indicates that the OA-QI questionnaire is acceptable to persons with OA, and its short format makes it suitable for population surveys. The low patient self-reported QI pass rates in this study suggest a potential for quality improvement in OA care.
Authors: Ilgin G Arslan; Rianne M Rozendaal; Marienke van Middelkoop; Saskia A G Stitzinger; Maarten-Paul Van de Kerkhove; Vincent M I Voorbrood; Patrick J E Bindels; Sita M A Bierma-Zeinstra; Dieuwke Schiphof Journal: RMD Open Date: 2021-05
Authors: Hema Umapathy; Kim Bennell; Chris Dickson; Fiona Dobson; Marlene Fransen; Graeme Jones; David J Hunter Journal: J Med Internet Res Date: 2015-07-07 Impact factor: 5.428
Authors: Krysia S Dziedzic; Emma L Healey; Mark Porcheret; Bie Nio Ong; Chris J Main; Kelvin P Jordan; Martyn Lewis; John J Edwards; Clare Jinks; Andrew Morden; Gretl A McHugh; Sarah Ryan; Andrew Finney; Sue Jowett; Raymond Oppong; Ebenezer Afolabi; Angela Pushpa-Rajah; June Handy; Kris Clarkson; Elizabeth Mason; Tracy Whitehurst; Rhian W Hughes; Peter R Croft; Elaine M Hay Journal: Implement Sci Date: 2014-08-27 Impact factor: 7.327
Authors: N Østerås; K P Jordan; B Clausen; C Cordeiro; K Dziedzic; J Edwards; G Grønhaug; A Higginbottom; H Lund; G Pacheco; S Pais; K B Hagen Journal: RMD Open Date: 2015-10-20
Authors: Linda Baumbach; Donna Ankerst; Ewa M Roos; Lillemor A Nyberg; Elizabeth Cottrell; Jesper Lykkegaard Journal: Scand J Prim Health Care Date: 2021-07-05 Impact factor: 2.581